The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Clopidogrel/Acetylsalicylic acid Zentiva

75 mg/75 milligram(s) Film-coated tablet

sanofi-aventis groupeEU/1/10/623/1-7

Main Information

Trade NameClopidogrel/Acetylsalicylic acid Zentiva
Active SubstancesAcetylsalicylic acid
Clopidogrel hydrogen sulphate
Strength75 mg/75 milligram(s)
Dosage FormFilm-coated tablet
Licence Holdersanofi-aventis groupe
Licence NumberEU/1/10/623/1-7

Group Information

ATC CodeB01AC Platelet aggregation inhibitors excl. heparin
B01AC30 combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued15/03/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0043-030-003
Interchangeable List DocumentPDF of Interchangeable List
« Back